
Under Rs 740 Stocks to Buy in November 2026: 5 Names on the Watchlist
ABCapital Rs 401.65. Dabur India Rs 375.25. LIC Rs 399.00. Metropolis Healthcare Rs 582.35. PN Gadgil Jewellers Rs 612.00. NSE closing prices, 9 Nov 2026.
Updated: 11 Nov 2026 • 1:25 pm
Posted by:

Quick Answer
Five under Rs 740 stocks to buy on the November 2026 watchlist are Aditya Birla Capital, Dabur India, Life Insurance Corporation of India, Metropolis Healthcare and PN Gadgil Jewellers. All five grew revenue in their latest full year, and all five also grew net profit. Life Insurance Corporation of India has both the lowest P/E at 8.33 and the highest return on equity at 32.53%. Check each valuation against your own risk appetite before acting.
The under Rs 740 stocks to buy in November 2026 start with five listed names: Aditya Birla Capital, Dabur India, Life Insurance Corporation of India, Metropolis Healthcare and PN Gadgil Jewellers. Stocks under Rs 740 include a financial services group, a consumer goods company, India's largest life insurer, a diagnostics chain and a jewellery retailer, priced from about Rs 375 to Rs 612. Dabur India is part of the Nifty FMCG index.
This article ranks none of them as a sure thing. It lays out the numbers each company has reported, how the shares are priced today and what an investor should check before adding any of these under Rs 740 stocks to buy to a portfolio. All prices are NSE closing prices of 9 November 2026, and financials come from company filings.
Click Here – Get Free Investment Predictions
Which Are the Best Under Rs 740 Stocks to Buy in November 2026?
The best under Rs 740 stocks to buy in November 2026 for a watchlist are Aditya Birla Capital, Dabur India, Life Insurance Corporation of India, Metropolis Healthcare and PN Gadgil Jewellers. They were picked because each has complete reported financials, profit in the latest quarter and an NSE listing. The table puts their market data side by side.
| Company | CMP (Rs) | Market Cap | P/E | ROE | Dividend Yield |
|---|---|---|---|---|---|
| Aditya Birla Capital | 401.65 | Rs 98,568 crore | 23.94 | 10.96% | 0.00% |
| Dabur India | 375.25 | Rs 64,040 crore | 32.91 | 16.59% | 2.28% |
| Life Insurance Corporation of India | 399.00 | Rs 4,99,928 crore | 8.33 | 32.53% | 1.27% |
| Metropolis Healthcare | 582.35 | Rs 11,493 crore | 56.65 | 12.56% | 0.90% |
| PN Gadgil Jewellers | 612.00 | Rs 8,434 crore | 18.92 | 20.88% | 0.00% |
On valuation, Life Insurance Corporation of India and PN Gadgil Jewellers trade below the industry P/E; Dabur India and Metropolis Healthcare sit close to it; Aditya Birla Capital carries a premium. Valuation is the first filter for any under Rs 740 stocks to buy list, and it is covered again in the risk section.
Why These Under Rs 740 Stocks to Buy Are in Focus
A mid-range share price does not mean a stock is inexpensive, because value depends on earnings and the number of shares. The list covers a diversified financial services group, the maker of Dabur and Real brands, the country's largest life insurer, a diagnostics chain and a regional jewellery retailer, all of which closed below Rs 740 on the NSE on 9 November. Investors searching for the best stocks under Rs 740 in India should check earnings, valuation and debt.
Aditya Birla Capital: The Group Financial Services Arm Among Under Rs 740 Stocks to Buy
Aditya Birla Capital is the financial services arm of the Aditya Birla Group, with lending, insurance and asset management. At Rs 401.65, the stock has a market capitalisation of Rs 98,568 crore and trades at 23.94 times earnings, while the industry P/E is 16.15.
Reported numbers show FY26 revenue of Rs 45,617 crore, up 12.0% year on year, with net profit at Rs 3,864 crore, up 14.2%. The June 2026 quarter added revenue of Rs 12,187 crore (up 27.9%) and net profit of Rs 1,224 crore (up 43.3%).
Return on equity is 10.96%, and the dividend yield is negligible. Promoters hold 68.82%, foreign institutions 8.92% and domestic institutions 13.38% as of September 2026. Foreign institutional holding has risen from 6.78% to 8.92% over the last year.
Dabur India: The Ayurveda-Led Name Among Under Rs 740 Stocks to Buy
Dabur India is an ayurveda and natural products company behind Dabur Chyawanprash, Real juices and Vatika. Its market capitalisation is Rs 64,040 crore, the share price is Rs 375.25 and the P/E of 32.91 compares with an industry P/E of 33.02.
Over FY26, net profit rose 7.4% to Rs 1,869 crore on revenue of Rs 13,792 crore, which was up 5.2%. The latest quarter, the June 2026 quarter, brought revenue of Rs 3,937 crore, up 10.9% year on year, and net profit of Rs 586 crore, up 15.3%.
Return on equity is 16.59%, debt-to-equity is 0.11, and the dividend yield is 2.28%. Promoters hold 66.25%, foreign institutions 9.61% and domestic institutions 18.35% as of September 2026.
Check Under Rs 740 Stocks Live on the Univest Screener
Life Insurance Corporation of India: The Insurance Giant Among Under Rs 740 Stocks to Buy
Life Insurance Corporation of India is India's largest life insurer, owned by the government. The stock trades at Rs 399.00 with a market capitalisation of Rs 4,99,928 crore and a P/E of 8.33, against an industry P/E of 10.22.
FY26 revenue rose 10.2% to Rs 9,90,211 crore and net profit rose 18.9% to Rs 57,453 crore. In the June 2026 quarter, revenue grew 7.0% year on year to Rs 2,41,166 crore, while net profit grew 24.0% to Rs 13,584 crore.
Return on equity is 32.53%, and the dividend yield is 1.27%. Promoters hold 90.00%, foreign institutions 1.55% and domestic institutions 6.17% as of September 2026. Domestic institutional holding has risen from 1.36% to 6.17% over the last year.
Metropolis Healthcare: The Diagnostics Network Among Under Rs 740 Stocks to Buy
Metropolis Healthcare is a diagnostics company with labs and collection centres across India and overseas. At Rs 582.35, the stock has a market capitalisation of Rs 11,493 crore and trades at 56.65 times earnings, while the industry P/E is 61.50.
Reported numbers show FY26 revenue of Rs 1,671 crore, up 24.1% year on year, with net profit at Rs 191 crore, up 31.4%. The June 2026 quarter added revenue of Rs 455 crore (up 15.7%) and net profit of Rs 56.9 crore (up 25.7%).
Return on equity is 12.56%, debt-to-equity is 0.15, and the dividend yield is 0.90%. Promoters hold 47.82%, foreign institutions 11.67% and domestic institutions 35.49% as of September 2026. Domestic institutional holding has risen from 33.10% to 35.49% over the last year.
PN Gadgil Jewellers: The Maharashtra Retailer Among Under Rs 740 Stocks to Buy
PN Gadgil Jewellers is a Pune-based jewellery retailer with a large store network in Maharashtra. Its market capitalisation is Rs 8,434 crore, the share price is Rs 612.00 and the P/E of 18.92 compares with an industry P/E of 44.29.
Over FY26, net profit rose 87.8% to Rs 410 crore on revenue of Rs 10,827 crore, which was up 40.2%. The latest quarter, the June 2026 quarter, brought revenue of Rs 2,423 crore, up 40.3% year on year, and net profit of Rs 105 crore, up 51.9%.
Return on equity is 20.88%, debt-to-equity is 0.89, and the dividend yield is negligible. Promoters hold 76.62%, foreign institutions 3.82% and domestic institutions 7.05% as of September 2026. Domestic institutional holding has risen from 4.80% to 7.05% over the last year. A point to keep in view: debt is higher than most names on this list.
Download the Univest iOS App or Univest Android App to track these under Rs 740 stocks live and get daily stock recommendations.
Growth Snapshot: Latest Full Year and Latest Quarter
The table compares year-on-year growth in revenue and net profit for all five under Rs 740 stocks, using filed results.
| Company | Full-Year Revenue Growth | Full-Year Profit Growth | Latest Quarter | Quarter Revenue Growth | Quarter Profit Growth |
|---|---|---|---|---|---|
| Aditya Birla Capital | 12.0% | 14.2% | Jun 2026 | 27.9% | 43.3% |
| Dabur India | 5.2% | 7.4% | Jun 2026 | 10.9% | 15.3% |
| Life Insurance Corporation of India | 10.2% | 18.9% | Jun 2026 | 7.0% | 24.0% |
| Metropolis Healthcare | 24.1% | 31.4% | Jun 2026 | 15.7% | 25.7% |
| PN Gadgil Jewellers | 40.2% | 87.8% | Jun 2026 | 40.3% | 51.9% |
Factors That Move Under Rs 740 Stocks to Buy
Four factors tend to drive under Rs 740 stocks, and each one is worth checking before a purchase.
- Earnings growth: Profit should be rising.
- Sector mix: Financial services, consumer goods, insurance, diagnostics and jewellery differ.
- Dividends: Dabur India yields about 2.3%.
- Valuation: P/E runs from about 8 to 57.
Risks to Keep in Mind Before Buying Under Rs 740 Stocks
The first risk is that a mid-range share price says little about value, so earnings and valuation matter more. The second is that Metropolis Healthcare trades at a P/E near 57 while Life Insurance Corporation of India trades near 8, and Aditya Birla Capital carries the highest borrowings of the five. Check results every quarter.
On the numbers, Metropolis Healthcare trades at the highest P/E on this list at 56.65, so its earnings need to keep growing to support the price. Under Rs 740 stocks to buy can still fall when markets turn weak, and a staggered entry has historically suited investors better than a lump-sum purchase.
How to Choose Under Rs 740 Stocks to Buy
- Look at earnings: Price alone is not a signal.
- Check P/E: Life Insurance Corporation of India trades lowest.
- Read ROE: Life Insurance Corporation of India leads.
- Diversify: Spread across the five sectors.
How to Invest in Under Rs 740 Stocks
- Shortlist two or three companies from this list that match your risk appetite.
- Open the Univest Screener and compare P/E, ROE and debt for each stock.
- Check the latest quarterly results and shareholding pattern on NSE or BSE.
- Decide an amount you can hold for three to five years and split it into two or three purchases.
- Review the holding after every quarterly result instead of reacting to daily price moves.
Conclusion
Life Insurance Corporation of India offers both the lowest P/E on this list at 8.33 and the highest return on equity at 32.53%, and PN Gadgil Jewellers posted the fastest net profit growth in its latest full year at 87.8%. Among the best under Rs 740 stocks in India, these five give investors a spread of size, valuation and growth, so the right pick depends on risk appetite and holding period. Spread the entry, keep position sizes sensible and consult a SEBI-registered advisor before investing in any of these under Rs 740 stocks to buy.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions on Under Rs 740 Stocks to Buy
Which are the best under Rs 740 stocks to buy in November 2026?
Ans. The five under Rs 740 stocks on the November 2026 watchlist are Aditya Birla Capital, Dabur India, Life Insurance Corporation of India, Metropolis Healthcare and PN Gadgil Jewellers. Life Insurance Corporation of India has both the lowest P/E at 8.33 and the highest ROE at 32.53%, and PN Gadgil Jewellers grew net profit 87.8% in its latest full year. This is educational content, not investment advice, so please consult a SEBI-registered advisor.
Is Life Insurance Corporation of India a good stock to buy from this Under Rs 740 list?
Ans. Life Insurance Corporation of India is the largest company on this list with a market capitalisation of Rs 4,99,928 crore and a P/E of 8.33 against an industry P/E of 10.22. Its FY26 revenue rose 10.2% and net profit rose 18.9%, with return on equity at 32.53%. Whether it suits you depends on your risk appetite and holding period, so please consult a SEBI-registered advisor before investing.
Are these under Rs 740 stocks expensive right now?
Ans. Valuations vary across the group. Aditya Birla Capital trades at a P/E of 23.94, Dabur India trades at a P/E of 32.91, Life Insurance Corporation of India trades at a P/E of 8.33, Metropolis Healthcare trades at a P/E of 56.65, PN Gadgil Jewellers trades at a P/E of 18.92, against industry multiples ranging from 10.22 to 61.50. Higher multiples reflect faster growth but also leave less room for earnings misses, so entry price deserves attention.
Which of these under Rs 740 stocks pay a dividend?
Ans. Dividend yields on this list are Dabur India 2.28%, Life Insurance Corporation of India 1.27%, Metropolis Healthcare 0.90%. Yields differ widely across the group, so check payout history and earnings cover before relying on any of them for income, since payouts can change with company profits.
Which stock on this list has the highest return on equity?
Ans. Life Insurance Corporation of India has the highest ROE on this list at 32.53%, followed by PN Gadgil Jewellers at 20.88% and Dabur India at 16.59%. A higher ROE shows a company earns more profit on shareholder capital, but it should be read alongside valuation and debt.
What are the risks of investing in under Rs 740 stocks?
Ans. The main risks are mid-range prices that say little about value, gold price swings and a very wide spread in valuations. On this list, Metropolis Healthcare trades at the highest P/E of 56.65, which leaves less room for earnings disappointments. Staggered buying and a long holding period can help manage these risks.
How can I invest in under Rs 740 stocks in India?
Ans. You can buy these stocks directly on NSE or BSE through a demat account, and compare them first on the Univest Screener using P/E, ROE and debt. Many investors split the amount across two or three purchases and review the holding after each quarterly result. Sector-themed mutual funds and ETFs are another route for investors who prefer diversification.
Recent Articles

3 Visa and Citizen Services Company, Engines and Power Generation Company and Pharmaceutical Company Stocks With a Strong Future Roadmap: BLS International Services, Cummins India and Emcure Pharmaceuticals
11 November 2026

3 Energy and Environment Solutions Company, Textiles and Garments Maker and Engineering Services Company Stocks With a Strong Future Roadmap: Thermax, KPR Mill and Tata Technologies
11 November 2026

3 Pharmaceutical Formulations Company, Crop Protection Chemicals Company and Laminated Tubes Packaging Maker Stocks With a Strong Future Roadmap: Alembic Pharmaceuticals, Sharda Cropchem and EPL
11 November 2026

3 Decorative Paints Company, Power Plant Services Company and Automotive Braking Systems Maker Stocks With a Strong Future Roadmap: Berger Paints India, Power Mech Projects and ASK Automotive
11 November 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
3 Visa and Citizen Services Company, Engines and Power Generation Company and Pharmaceutical Company Stocks With a Strong Future Roadmap: BLS International Services, Cummins India and Emcure Pharmaceuticals
3 Energy and Environment Solutions Company, Textiles and Garments Maker and Engineering Services Company Stocks With a Strong Future Roadmap: Thermax, KPR Mill and Tata Technologies
3 Pharmaceutical Formulations Company, Crop Protection Chemicals Company and Laminated Tubes Packaging Maker Stocks With a Strong Future Roadmap: Alembic Pharmaceuticals, Sharda Cropchem and EPL
3 Decorative Paints Company, Power Plant Services Company and Automotive Braking Systems Maker Stocks With a Strong Future Roadmap: Berger Paints India, Power Mech Projects and ASK Automotive
3 Jewellery Retailer, Hospital Network Operator and Transmission Towers Maker Stocks With a Strong Future Roadmap: Senco Gold, Max Healthcare Institute and Skipper

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
for Startups Accelerator 2024
Trusted by 1Cr Indians
Awarded No.1 by Economic Times





